OTC · Medical - Care Facilities

BioCorRx Inc. (BICX) Stock

$0.30 +0.00% OTC: BICX Healthcare

BioCorRx Inc. (BICX), through its various operations, is dedicated to creating and delivering therapeutic solutions for individuals struggling with substance dependence and related health conditions across the United States.

Valuation

MetricValue
Price$0.30
Market Cap$6.26M
P/E Ratio-1.80
P/B Ratio-0.67
P/S Ratio7.14
EPS (TTM)$-0.19
52-Week High$1.28
52-Week Low$0.20
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE28.12%
ROA-147.53%
ROCE78.09%
Gross Margin83.96%
Operating Margin-552.33%
Net Margin-391.15%
Debt/Equity-0.18
Current Ratio0.12

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$1.0M
Operating Profit$-5.0M$-3.0M$-4.0M$-5.0M$-5.0M
Net Profit$-6.0M$-4.0M$-4.0M$-5.0M$-3.0M
EPS$-0.89$-0.61$-0.45$-0.49$-0.19
Op Margin-9389.9%-1360.1%-4248.3%-66829.8%-606.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.0M$1.0M$0$0$2.0M
Total Liabilities$8.0M$9.0M$10.0M$13.0M$14.0M
Cash$0$0$0$0$0
Borrowings$2.0M$2.0M$2.0M$7.0M$2.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-4.0M$-2.0M$-2.0M$-1.0M$-2.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$2.0M$1.0M$0$0$0
Net Cash Flow$-1.0M$0$0$0$0
Free Cash Flow$-4.0M$-2.0M$-2.0M$-1.0M$-2.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-2.76
FCF Yield-32.60%
Quick Ratio0.10
Interest Coverage-6.21
Return 1Y-30.23%
Return 3Y-86.11%
Return 5Y—

Ownership

Insiders Held61.36%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About BioCorRx Inc.

BioCorRx Inc. (BICX), through its various operations, is dedicated to creating and delivering therapeutic solutions for individuals struggling with substance dependence and related health conditions across the United States. Among its core offerings is the BioCorRx recovery program, an innovative, non-addictive treatment model. This program uniquely combines proprietary naltrexone implants with extensive counseling services to support patient recovery. Additionally, the company provides the UnCraveRx weight management program, a medically supported initiative designed to curb food cravings. This program integrates pharmacological assistance with readily available virtual support focusing on lifestyle adjustments, fitness, and nutritional guidance. Looking to the future, BioCorRx is actively advancing its product pipeline. This includes BICX101, an injectable naltrexone product, and BICX104, an implantable naltrexone device, both currently under development for the specific treatment of opioid addiction and alcoholism. The company's programs are made available to patients through a network of healthcare providers, independent licensed clinics, and other qualified healthcare professionals. Originally established as Fresh Start Private Management, Inc., the organization officially rebranded as BioCorRx Inc. in January 2014. Its corporate headquarters are situated in Anaheim, California.

BioCorRx Inc. is headquartered in US.

BioCorRx Inc. (BICX) stock trades at $0.30 with a market capitalization of $6.26M. The stock is valued at a price-to-earnings (P/E) ratio of -1.80, price-to-book of -0.67, price-to-sales of 7.14. Over the past 52 weeks the stock has ranged between $0.20 and $1.28, and currently trades 76.6% below its 52-week high.

On profitability, BioCorRx Inc. generates a return on equity (ROE) of 28.12% — well above the market average, a sign of a high-quality business, return on capital employed of 78.09%, an operating margin of -552.33%, a net profit margin of -391.15%.

Official website: www.biocorrx.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides